• 1
    Bernstein CN, Leslie WD 2003 The pathophysiology of bone disease in gastrointestinal disease. Eur J Gastroenterol Hepatol 15:857864.
  • 2
    Schlemmer A, Hassager C 1999 Acute fasting diminishes the circadian rhythm of biochemical markers of bone resorption. Eur J Endocrinol 140:332337.
  • 3
    Christgau S 2000 Circadian variation in serum CrossLaps concentration is reduced in fasting individuals. Clin Chem 46:431.
  • 4
    Bjarnason NH, Henriksen EE, Alexandersen P, Christgau S, Henriksen DB, Christiansen C 2002 Mechanism of circadian variation in bone resorption. Bone 30:307313.
  • 5
    Clowes JA, Yap TS, Li J, Hoyle N, Blumsohn A, Hannon RA, Eastell R 2002 The Effect of Feeding on Bone Turnover Markers and its Impact on Biological Variability of Measurements. Bone 30:886890.
  • 6
    Clowes JA, Allen HC, Prentis DM, Eastell R, Blumsohn A 2003 Octreotide abolishes the acute decrease in bone turnover in response to oral glucose. J Clin Endocrinol Metab 88:48674873.
  • 7
    Henriksen DB, Alexandersen P, Bjarnason NH, Vilsboll T, Hartmann B, Henriksen EE, Byrjalsen I, Krarup T, Holst JJ, Christiansen C 2003 Role of gastrointestinal hormones in postprandial reduction of bone resorption. J Bone Miner Res 18:21802189.
  • 8
    Li F, Muhlbauer RC 1999 Food fractionation is a powerful tool to increase bone mass in growing rats and to decrease bone loss in aged rats: Modulation of the effect by dietary phosphate. J Bone Miner Res 14:14571465.
  • 9
    Rodgers JT, Lerin C, Haas W, Gygi SP, Spiegelman BM, Puigserver P 2005 Nutrient control of glucose homeostasis through a complex of PGC-1alpha and SIRT1. Nature 434:113118.
  • 10
    Blumsohn A, Herrington K, Hannon RA, Shao P, Eyre DR, Eastell R 1994 The effect of calcium supplementation on the circadian rhythm of bone resorption. J Clin Endocrinol Metab 79:730735.
  • 11
    Rubinacci A, Melzi R, Zampino M, Soldarini A, Villa I 1999 Total and free deoxypyridinoline after acute osteoclast activity inhibition. Clin Chem 45:15101516.
  • 12
    Villa I, Saccon B, Rubinacci A 2000 Response to acute osteoclast activity inhibition assessed by the determination of C-telopeptide of type I collagen in serum. Clin Chem 46:567569.
  • 13
    Scopacasa F, Need AG, Horowitz M, Wishart JM, Morris HA, Nordin BE 2000 Inhibition of bone resorption by divided-dose calcium supplementation in early postmenopausal women. Calcif Tissue Int 67:440442.
  • 14
    Horowitz M, Wishart JM, Goh D, Morris HA, Need AG, Nordin BE 1994 Oral calcium suppresses biochemical markers of bone resorption in normal men. Am J Clin Nutr 60:965968.
  • 15
    Walton RJ, Preston CJ, Russell RG, Kanis JA 1975 An estimate of the turnover rate of bone-derived plasma alkaline phosphatase in Paget's disease. Clin Chim Acta 63:227229.
  • 16
    Brochmann Murray EJ, Beamer WG, Duarte ME, Behnam K, Grisanti MS, Murray SS 2001 Effects of dietary restriction on appendicular bone in the SENCAR mouse. Metabolism 50:436442.
  • 17
    Muhlbauer RC, Fleisch H 1995 The diurnal rhythm of bone resorption in the rat. Effect of feeding habits and pharmacological inhibitors. J Clin Invest 95:19331940.
  • 18
    Srivastava AK, Bhattacharyya S, Li X, Mohan S, Baylink DJ 2001 Circadian and longitudinal variation of serum C-telopeptide, osteocalcin, and skeletal alkaline phosphatase in C3H/HeJ mice. Bone 29:361367.
  • 19
    Shinoda H, Stern PH 1992 Diurnal rhythms in Ca transfer into bone, Ca release from bone, and bone resorbing activity in serum of rats. Am J Physiol 262:R235R240.
  • 20
    Fraser WD, Logue FC, Christie JP, Cameron DA, O'Reilly DS, Beastall GH 1994 Alteration of the circadian rhythm of intact parathyroid hormone following a 96-hour fast. Clin Endocrinol (Oxf) 40:523528.
  • 21
    Ledger GA, Burritt MF, Kao PC, O'Fallon WM, Riggs BL, Khosla S 1995 Role of parathyroid hormone in mediating nocturnal and age-related increases in bone resorption. J Clin Endocrinol Metab 80:33043310.
  • 22
    Wass JA, Penman E, Dryburgh JR, Tsiolakis D, Goldberg PL, Dawson AM, Besser GM, Rees LH 1980 Circulating somatostatin after food and glucose in man. Clin Endocrinol (Oxf) 12:569574.
  • 23
    Tse TF, Clutter WE, Shah SD, Miller JP, Cryer PE 1983 Neuroendocrine responses to glucose ingestion in man. Specificity, temporal relationships, and quantitative aspects. J Clin Invest 72:270277.
  • 24
    Morgan LM 1996 The metabolic role of GIP: Physiology and pathology. Biochem Soc Trans 24:585591.
  • 25
    Austin LA, Heath H III 1981 Calcitonin: Physiology and pathophysiology. N Engl J Med 304:269278.
  • 26
    Bollag RJ, Zhong Q, Phillips P, Min L, Zhong L, Cameron R, Mulloy AL, Rasmussen H, Qin F, Ding KH, Isales CM 2000 Osteoblast-derived cells express functional glucose-dependent insulinotropic peptide receptors. Endocrinology 141:12281235.
  • 27
    Cornish J, Callon KE, Bava U, Kamona SA, Cooper GJ, Reid IR 2001 Effects of calcitonin, amylin, and calcitonin gene-related peptide on osteoclast development. Bone 29:162168.
  • 28
    Khosla S 2002 Leptin-central or peripheral to the regulation of bone metabolism? Endocrinology 143:41614164.
  • 29
    Thamsborg G, Jensen JE, Kollerup G, Hauge EM, Melsen F, Sorensen OH 1996 Effect of nasal salmon calcitonin on bone remodeling and bone mass in postmenopausal osteoporosis. Bone 18:207212.
  • 30
    Schwille PO, Schmiedl A, Herrmann U, Schwille R, Fink E, Manoharan M 1997 Acute oral calcium-sodium citrate load in healthy males. Effects on acid-base and mineral metabolism, oxalate and other risk factors of stone formation in urine. Methods Find Exp Clin Pharmacol 19:417427.
  • 31
    Cornish J, Callon KE, King AR, Cooper GJ, Reid IR 1998 Systemic administration of amylin increases bone mass, linear growth, and adiposity in adult male mice. Am J Physiol 275:E694E699.
  • 32
    Cornish J, Callon KE, Gasser JA, Bava U, Gardiner EM, Coy DH, Cooper GJ, Reid IR 2000 Systemic administration of a novel octapeptide, amylin-(1–8), increases bone volume in male mice. Am J Physiol Endocrinol Metab 279:E730E735.
  • 33
    Bollag RJ, Zhong Q, Ding KH, Phillips P, Zhong L, Qin F, Cranford J, Mulloy AL, Cameron R, Isales CM 2001 Glucose-dependent insulinotropic peptide is an integrative hormone with osteotropic effects. Mol Cell Endocrinol 177:3541.
  • 34
    Haderslev KV, Jeppesen PB, Hartmann B, Thulesen J, Sorensen HA, Graff J, Hansen BS, Tofteng F, Poulsen SS, Madsen JL, Holst JJ, Staun M, Mortensen PB 2002 Short-term administration of glucagon-like peptide-2. Effects on bone mineral density and markers of bone turnover in short-bowel patients with no colon. Scand J Gastroenterol 37:392398.
  • 35
    Tse TF, Clutter WE, Shah SD, Cryer PE 1983 Mechanisms of postprandial glucose counterregulation in man. Physiologic roles of glucagon and epinephrine vis-a-vis insulin in the prevention of hypoglycemia late after glucose ingestion. J Clin Invest 72:278286.
  • 36
    Heshmati HM, Riggs BL, Burritt MF, McAlister CA, Wollan PC, Khosla S 1998 Effects of the circadian variation in serum cortisol on markers of bone turnover and calcium homeostasis in normal postmenopausal women. J Clin Endocrinol Metab 83:751756.
  • 37
    Lakatos P, Blumsohn A, Eastell R, Tarjan G, Shinoda H, Stern PH 1995 Circadian rhythm of in vitro bone-resorbing activity in human serum. J Clin Endocrinol Metab 80:31853190.
  • 38
    Dockray GJ, Varro A, Dimaline R, Wang T 2001 The gastrins: Their production and biological activities. Annu Rev Physiol 63:119139.
  • 39
    Thomas DM, Udagawa N, Hards DK, Quinn JM, Moseley JM, Findlay DM, Best JD 1998 Insulin receptor expression in primary and cultured osteoclast-like cells. Bone 23:181186.
  • 40
    Williams JP, Blair HC, McDonald JM, McKenna MA, Jordan SE, Williford J, Hardy RW 1997 Regulation of osteoclastic bone resorption by glucose. Biochem Biophys Res Commun 235:646651.
  • 41
    Clowes JA, Robinson RT, Heller SR, Eastell R, Blumsohn A 2002 Acute changes of bone turnover and parathyroid hormone induced by insulin and glucose: Euglycemic and hypoglycemic hyperinsulinemic clamp studies. J Clin Endocrinol Metab 87:33233329.
  • 42
    DeFronzo RA, Cooke CR, Andres R, Faloona GR, Davis PJ 1975 The effect of insulin on renal handling of sodium, potassium, calcium, and phosphate in man. J Clin Invest 55:845855.
  • 43
    DeFronzo RA, Goldberg M, Agus ZS 1976 The effects of glucose and insulin on renal electrolyte transport. J Clin Invest 58:8390.
  • 44
    Nowicki M, Kokot F, Surdacki A 1998 The influence of hyperinsulinaemia on calcium-phosphate metabolism in renal failure. Nephrol Dial Transplant 13:25662571.
  • 45
    Ohno Y, Suzuki H, Yamakawa H, Nakamura M, Saruta T 2000 Insulin sensitivity and calcium homeostasis in young, lean, normotensive male subjects. Hypertens Res 23:433440.
  • 46
    Rumenapf G, Schmidtler J, Schwille PO 1990 Intestinal calcium absorption during hyperinsulinemic euglycemic glucose clamp in healthy humans. Calcif Tissue Int 46:7379.
  • 47
    Williams GA, Hargis GK, Ensinck JW, Kukreja SC, Bowser EN, Chertow BS, Henderson WJ 1979 Role of endogenous somatostatin in the secretion of parathyroid hormone and calcitonin. Metabolism 28:950954.
  • 48
    Fuessl HS, Burrin JM, Williams G, Adrian TE, Bloom SR 1987 The effect of a long-acting somatostatin analogue (SMS 201-995) on intermediary metabolism and gut hormones after a test meal in normal subjects. Aliment Pharmacol Ther 1:321330.
  • 49
    Lamberts SW 1988 The role of somatostatin in the regulation of anterior pituitary hormone secretion and the use of its analogs in the treatment of human pituitary tumors. Endocr Rev 9:417436.
  • 50
    Cornish J, Callon KE, Lin CQ, Xiao CL, Mulvey TB, Coy DH, Cooper GJ, Reid IR 1998 Dissociation of the effects of amylin on osteoblast proliferation and bone resorption. Am J Physiol 274:E827E833.
  • 51
    Cornish J, Callon KE, Lin CQ, Xiao CL, Gamble GD, Cooper GJ, Reid IR 1999 Comparison of the effects of calcitonin gene-related peptide and amylin on osteoblasts. J Bone Miner Res 14:13021309.
  • 52
    Karsdal MA, Holst JJ, Henriksen D 2004 GLP-2 reduces bone resorption in vitro via the osteoclast GLP-2 receptor. J Bone Miner Res 19:S1S416.
  • 53
    Xie D, Ding KH, Hamrick M, Mulloy AL, Insogna K, Isales CM 2004 Glucose-dependent insulinotropic peptide regulates bone turnover in vivo. J Bone Miner Res 19:S1S462.
  • 54
    Dacquin R, Davey RA, Laplace C, Levasseur R, Morris HA, Goldring SR, Gebre-Medhin S, Galson DL, Zajac JD, Karsenty G 2004 Amylin inhibits bone resorption while the calcitonin receptor controls bone formation in vivo. J Cell Biol 164:509514.
  • 55
    Cornish J, Callon KE, Bava U, Lin C, Naot D, Hill BL, Grey AB, Broom N, Myers DE, Nicholson GC, Reid IR 2002 Leptin directly regulates bone cell function in vitro and reduces bone fragility in vivo. J Endocrinol 175:405415.
  • 56
    Coleman RA, Herrmann TS 1999 Nutritional regulation of leptin in humans. Diabetologia 42:639646.
  • 57
    Holloway WR, Collier FM, Aitken CJ, Myers DE, Hodge JM, Malakellis M, Gough TJ, Collier GR, Nicholson GC 2002 Leptin inhibits osteoclast generation. J Bone Miner Res 17:200209.
  • 58
    Dempster DW, Hughes-Begos CE, Plavetic-Chee K, Brandao-Burch A, Cosman F, Nieves J, Neubort S, Lu SS, Iida-Klein A, Arnett T, Lindsay R 2005 Normal human osteoclasts formed from peripheral blood monocytes express PTH type 1 receptors and are stimulated by PTH in the absence of osteoblasts. J Cell Biochem 95:139148.
  • 59
    Sugimoto T, Ritter C, Morrissey J, Hayes C, Slatopolsky E 1990 Effects of high concentrations of glucose on PTH secretion in parathyroid cells. Kidney Int 37:15221527.
  • 60
    Hinton DA, MacGregor RR 1991 Effects of insulin on the synthesis, intracellular degradation, and secretion of parathormone. Endocrinology 128:488495.
  • 61
    Sethi R, Kukreja SC, Bowser EN, Hargis GK, Henderson WJ, Williams GA 1983 Effect of meal on serum parathyroid hormone and calcitonin: Possible role of secretin. J Clin Endocrinol Metab 56:549552.
  • 62
    D'Erasmo E, Pisani D, Ragno A, Raejntroph N, Vecci E, Acca M 1999 Calcium homeostasis during oral glucose load in healthy women. Horm Metab Res 31:271273.
  • 63
    Shearing CH, Ashby JP, Hepburn DA, Fisher BM, Frier BM 1992 Suppression of plasma intact parathyroid hormone levels during insulin- induced hypoglycemia in humans. J Clin Endocrinol Metab 74:12701276.
  • 64
    Nowicki M, Fliser D, Fode P, Ritz E 1996 Changes in plasma phosphate levels influence insulin sensitivity under euglycemic conditions. J Clin Endocrinol Metab 81:156159.
  • 65
    Reeve J, Hesp R, Wootton R 1976 A new tracer method for the calculation of rates of bone formation and breakdown in osteoporosis and other generalised skeletal disorders. Calcif Tissue Res 22:191206.
  • 66
    Li H, Seitz PK, Thomas ML, Selvanayagam P, Rajaraman S, Cooper CW 1995 Widespread expression of the parathyroid hormone-related peptide and PTH/PTHrP receptor genes in intestinal epithelial cells. Lab Invest 73:864870.
  • 67
    Sawada Y, Zhang B, Okajima F, Izumi T, Takeuchi T 2001 PTHrP increases pancreatic beta-cell-specific functions in well-differentiated cells. Mol Cell Endocrinol 182:265275.
  • 68
    Zaidi M, Moonga BS, Abe E 2002 Calcitonin and bone formation: A knockout full of surprises. J Clin Invest 110:17691771.
  • 69
    Hirsch PF, Hagaman JR 1982 Feeding regimen, dietary calcium, and the diurnal rhythms of serum calcium and calcitonin in the rat. Endocrinology 110:961968.
  • 70
    Owyang C, Heath H III, Sizemore GW, Go VL 1978 Comparison of the effects of pentagastrin and meal-stimulated gastrin on plasma calcitonin in normal man. Am J Dig Dis 23:10841088.
  • 71
    Filipponi P, Gregorio F, Cristallini S, Mannarelli C, Blass A, Scarponi AM, Vespasiani G 1990 Partial gastrectomy and mineral metabolism: Effects on gastrin- calcitonin release. Bone Miner 11:199208.
  • 72
    Hoff AO, Catala-Lehnen P, Thomas PM, Priemel M, Rueger JM, Nasonkin I, Bradley A, Hughes MR, Ordonez N, Cote GJ, Amling M, Gagel RF 2002 Increased bone mass is an unexpected phenotype associated with deletion of the calcitonin gene. J Clin Invest 110:18491857.
  • 73
    Ohlsson C, Bengtsson BA, Isaksson OG, Andreassen TT, Slootweg MC 1998 Growth hormone and bone. Endocr Rev 19:5579.
  • 74
    Rajaram S, Baylink DJ, Mohan S 1997 Insulin-like growth factor-binding proteins in serum and other biological fluids: Regulation and functions. Endocr Rev 18:801831.
  • 75
    Ho KY, Veldhuis JD, Johnson ML, Furlanetto R, Evans WS, Alberti KG, Thorner MO 1988 Fasting enhances growth hormone secretion and amplifies the complex rhythms of growth hormone secretion in man. J Clin Invest 81:968975.
  • 76
    Thissen JP, Ketelslegers JM, Underwood LE 1994 Nutritional regulation of the insulin-like growth factors. Endocr Rev 15:80101.
  • 77
    Ebeling PR, Butler PC, Eastell R, Rizza RA, Riggs BL 1991 The nocturnal increase in growth hormone is not the cause of the nocturnal increase in serum osteocalcin. J Clin Endocrinol Metab 73:368372.
  • 78
    Muller AF, Lamberts SW, Janssen JA, Hofland LJ, Koetsveld PV, Bidlingmaier M, Strasburger CJ, Ghigo E, Van Der Lely AJ 2002 Ghrelin drives GH secretion during fasting in man. Eur J Endocrinol 146:203207.
  • 79
    Maccarinelli G, Sibilia V, Torsello A, Raimondo F, Pitto M, Giustina A, Netti C, Cocchi D 2005 Ghrelin regulates proliferation and differentiation of osteoblastic cells. J Endocrinol 184:249256.
  • 80
    Dixit VD, Schaffer EM, Pyle RS, Collins GD, Sakthivel SK, Palaniappan R, Lillard JW Jr, Taub DD 2004 Ghrelin inhibits leptin- and activation-induced proinflammatory cytokine expression by human monocytes and T cells. J Clin Invest 114:5766.
  • 81
    Sibilia V, Cocchi D, Pagani F, Lattuada N, Moro GL, Pecile A, Rubinacci A, Muller EE, Netti C 1999 Hexarelin, a growth hormone - releasing peptide, counteracts bone loss in gonadectomized male rats. Growth Horm IGF Res 9:219227.
  • 82
    Sibilia V, Cocchi D, Villa I, Lattuada N, Soglian A, Rubinacci A, Muller EE, Pecile A, Netti C 2002 Bone effects of hexarelin, a GH-releasing peptide, in female rats: Influence of estrogen milieu. Eur J Endocrinol 146:855862.
  • 83
    Sun Y, Ahmed S, Smith RG 2003 Deletion of ghrelin impairs neither growth nor appetite. Mol Cell Biol 23:79737981.
  • 84
    Bellone S, Castellino N, Broglio F, Rapa A, Vivenza D, Radetti G, Bellone J, Gottero C, Ghigo E, Bona G 2004 Ghrelin secretion in childhood is refractory to the inhibitory effect of feeding. J Clin Endocrinol Metab 89:16621665.
  • 85
    Henriksen DB, Hartman B, Jeppesen PB, Miholic J, Christiansen C, Holst JJ 2004 The postprandial bone resorption process is regulated by gastrointestinal signal. J Bone Miner Res 19:S1S92.
  • 86
    Kocian J, Brodan V 1979 Simultaneous correction of Ca deficiency and acidosis in fasting obese patients as a prevention of bone demineralisation. Nutr Metab 23:391398.
  • 87
    Rizzoli R, Bonjour JP 2004 Dietary protein and bone health. J Bone Miner Res 19:527531.
  • 88
    Muhlbauer RC, Lozano A, Reinli A 2002 Onion and a mixture of vegetables, salads, and herbs affect bone resorption in the rat by a mechanism independent of their base excess. J Bone Miner Res 17:12301236.
  • 89
    Lehto-Axtelius D, Chen D, Surve VV, Hakanson R 2002 Post-gastrectomy osteopenia in the rat: Bone structure is preserved by retaining 10%–30% of the oxyntic gland area. Scand J Gastroenterol 37:437443.
  • 90
    Berga SL, Loucks TL, Cameron JL 2001 Endocrine and chronobiological effects of fasting in women. Fertil Steril 75:926932.
  • 91
    Cameron JL, Weltzin TE, McConaha C, Helmreich DL, Kaye WH 1991 Slowing of pulsatile luteinizing hormone secretion in men after forty-eight hours of fasting. J Clin Endocrinol Metab 73:3541.
  • 92
    Brundin T 1999 Splanchnic and extrasplanchnic extraction of insulin following oral and intravenous glucose loads. Clin Sci (Lond) 97:429436.
  • 93
    Samnegard B, Brundin T 2001 Renal extraction of insulin and C-peptide in man before and after a glucose meal. Clin Physiol 21:164171.
  • 94
    Smedsrod B, Johansson S, Pertoft H 1985 Studies in vivo and in vitro on the uptake and degradation of soluble collagen alpha 1(I) chains in rat liver endothelial and Kupffer cells. Biochem J 228:415424.
  • 95
    Melick RA, Farrugia W, Heaton CL, Quelch KJ, Scoggins BA, Wark JD 1988 The metabolic clearance rate of osteocalcin in sheep. Calcif Tissue Int 42:185190.
  • 96
    Colwell A, Eastell R 1996 The renal clearance of free and conjugated pyridinium cross-links of collagen. J Bone Miner Res 11:19761980.
  • 97
    Colwell A, Russell RG, Eastell R 1993 Factors affecting the assay of urinary 3-hydroxy pyridinium crosslinks of collagen as markers of bone resorption. Eur J Clin Invest 23:341349.
  • 98
    Muhlbauer RC, Li F 1999 Effect of vegetables on bone metabolism. Nature 401:343344.
  • 99
    Muhlbauer RC, Lozano A, Reinli A, Wetli H 2003 Various selected vegetables, fruits, mushrooms and red wine residue inhibit bone resorption in rats. J Nutr 133:35923597.
  • 100
    Muhlbauer RC, Lozano A, Palacio S, Reinli A, Felix R 2003 Common herbs, essential oils, and monoterpenes potently modulate bone metabolism. Bone 32:372380.
  • 101
    Kha HT, Basseri B, Shouhed D, Richardson J, Tetradis S, Hahn TJ, Parhami F 2004 Oxysterols regulate differentiation of mesenchymal stem cells: Pro-bone and anti-fat. J Bone Miner Res 19:830840.
  • 102
    Wattel A, Kamel S, Prouillet C, Petit JP, Lorget F, Offord E, Brazier M 2004 Flavonoid quercetin decreases osteoclastic differentiation induced by RANKL via a mechanism involving NF kappa B and AP-1. J Cell Biochem 92:285295.
  • 103
    Shea B, Wells G, Cranney A, Zytaruk N, Robinson V, Griffith L, Ortiz Z, Peterson J, Adachi J, Tugwell P, Guyatt G 2002 Meta-analyses of therapies for postmenopausal osteoporosis. VII. Meta-analysis of calcium supplementation for the prevention of postmenopausal osteoporosis. Endocr Rev 23:552559.
  • 104
    New SA, Robins SP, Campbell MK, Martin JC, Garton MJ, Bolton-Smith C, Grubb DA, Lee SJ, Reid DM 2000 Dietary influences on bone mass and bone metabolism: Further evidence of a positive link between fruit and vegetable consumption and bone health? Am J Clin Nutr 71:142151.
  • 105
    Tucker KL, Chen H, Hannan MT, Cupples LA, Wilson PW, Felson D, Kiel DP 2002 Bone mineral density and dietary patterns in older adults: The Framingham Osteoporosis Study. Am J Clin Nutr 76:245252.
  • 106
    Tylavsky FA, Holliday K, Danish R, Womack C, Norwood J, Carbone L 2004 Fruit and vegetable intakes are an independent predictor of bone size in early pubertal children. Am J Clin Nutr 79:311317.
  • 107
    Taranta A, Fortunati D, Longo M, Rucci N, Iacomino E, Aliberti F, Facciuto E, Migliaccio S, Bardella MT, Dubini A, Borghi MO, Saraifoger S, Teti A, Bianchi ML 2004 Imbalance of osteoclastogenesis-regulating factors in patients with celiac disease. J Bone Miner Res 19:11121121.
  • 108
    Jeppesen PB, Hartmann B, Thulesen J, Graff J, Lohmann J, Hansen BS, Tofteng F, Poulsen SS, Madsen JL, Holst JJ, Mortensen PB 2001 Glucagon-like peptide 2 improves nutrient absorption and nutritional status in short-bowel patients with no colon. Gastroenterology 120:806815.
  • 109
    Goldstone AP, Howard JK, Lord GM, Ghatei MA, Gardiner JV, Wang ZL, Wang RM, Girgis SI, Bailey CJ, Bloom SR 2002 Leptin prevents the fall in plasma osteocalcin during starvation in male mice. Biochem Biophys Res Commun 295:475481.
  • 110
    Ravn P, Cizza G, Bjarnason NH, Thompson D, Daley M, Wasnich RD, McClung M, Hosking D, Yates AJ, Christiansen C 1999 Low body mass index is an important risk factor for low bone mass and increased bone loss in early postmenopausal women. Early Postmenopausal Intervention Cohort (EPIC) study group. J Bone Miner Res 14:16221627.
  • 111
    Ensrud KE, Cauley J, Lipschutz R, Cummings SR 1997 Weight change and fractures in older women. Study of Osteoporotic Fractures Research Group. Arch Intern Med 157:857863.
  • 112
    Riis BJ, Rodbro P, Christiansen C 1986 The role of serum concentrations of sex steroids and bone turnover in the development and occurrence of postmenopausal osteoporosis. Calcif Tissue Int 38:318322.
  • 113
    Nguyen TV, Howard GM, Kelly PJ, Eisman JA 1998 Bone mass, lean mass, and fat mass: Same genes or same environments? Am J Epidemiol 147:316.
  • 114
    Yamauchi M, Sugimoto T, Yamaguchi T, Nakaoka D, Kanzawa M, Yano S, Ozuru R, Sugishita T, Chihara K 2001 Plasma leptin concentrations are associated with bone mineral density and the presence of vertebral fractures in postmenopausal women. Clin Endocrinol (Oxf) 55:341347.
  • 115
    Klein GL, Ament ME, Coburn JW 1981 Metabolic bone disease in total parenteral nutrition. Lancet 1:835.
  • 116
    Hamilton C, Seidner DL 2004 Metabolic bone disease and parenteral nutrition. Curr Gastroenterol Rep 6:335341.